Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alan Salzman
Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus
JAMA - Journal of the American Medical Association
Medicine
Related publications
Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus
International Journal of Basic and Clinical Pharmacology
Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
Rosiglitazone in Combination With Glimepiride Plus Metformin in Type 2 Diabetic Patients
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Metformin Use and Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus
MVP Journal of Medical Sciences
A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus
International Journal of Basic & Clinical Pharmacology
Combination of Empagliflozin and Metformin Therapy: A Consideration of Its Place in Type 2 Diabetes Therapy
Clinical Medicine Insights: Endocrinology and Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pioglitazone and Metformin Fixed-Dose Combination in Type 2 Diabetes Mellitus: An Evidence-Based Review of Its Place in Therapy
Core Evidence
Medicine
Reviews
References
Pharmacology
Factors Associated With Clinical Inertia in Type 2 Diabetes Mellitus Patients Treated With Metformin Monotherapy
Current Medical Research and Opinion
Medicine
